Clinical bottom line
Robotic-assisted total hip arthroplasty (THA) demonstrates improved accuracy in implant positioning and restoration of limb length and offset compared to conventional techniques. Meta-analyses indicate potential benefits in early functional outcomes and reduced complication rates, although long-term clinical advantages remain to be conclusively established. Increased operative time and cost are notable considerations. Current evidence supports robotic assistance as a safe and effective adjunct in THA, particularly for complex cases requiring precise implant alignment (Llombart-Blanco et al., 2024; Chen et al., 2018).
What the evidence shows
Llombart-Blanco et al. (2024) conducted a comprehensive meta-analysis of MAKO robotic-assisted THA, reporting significantly improved accuracy in cup positioning within the safe zone and better restoration of hip biomechanics. Their analysis included randomized controlled trials and observational studies, showing lower rates of dislocation and revision surgery in robotic-assisted groups.
Chen et al. (2018) performed a systematic review and meta-analysis comparing robotic-assisted with conventional THA, finding that robotic assistance reduced outliers in implant alignment and improved early postoperative function. However, differences in long-term implant survival were not statistically significant.
Buchan et al. (2025) evaluated a novel fluoroscopy-based robotic system, demonstrating precise restoration of limb length and offset, key factors influencing postoperative gait and patient satisfaction.
Shao et al. (2022) provide a detailed overview of robotic-assisted THA principles, emphasizing the role of preoperative planning and intraoperative navigation in enhancing surgical precision.
Cross et al. (2014) critically appraised robotic THA, acknowledging improved accuracy but highlighting the need for further evidence on cost-effectiveness and long-term outcomes.
Caveats and uncertainty
Most studies have relatively short follow-up periods, limiting assessment of implant longevity and functional durability.
Heterogeneity in robotic platforms and surgeon experience complicates generalizability.
Increased operative time and resource utilization may impact workflow and healthcare costs.
Learning curves associated with robotic systems require consideration in training and credentialing.
Patient-reported outcomes and quality-of-life measures are inconsistently reported.
How this may change practice
Surgeons may consider robotic-assisted THA to enhance implant positioning accuracy, particularly in anatomically complex or revision cases.
Integration of robotic systems requires institutional investment and training but may improve surgical precision and reduce complications.
Shared decision-making with patients should include discussion of potential benefits, limitations, and costs of robotic-assisted surgery.
Future adoption may be guided by accumulating evidence on long-term outcomes and cost-effectiveness.
Multidisciplinary collaboration between surgeons, engineers, and administrators is essential to optimize implementation.